AIMT

Aimmune Therapeutics
AIMT

Delisted

AIMT was delisted on the 12th of October, 2020.

Back to rankings

58 hedge funds and large institutions have $551M invested in Aimmune Therapeutics in 2015 Q3 according to their latest regulatory filings, with 58 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

Upgrade to unlock
New
Increased
Maintained
Reduced
Closed
Holders
58
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
2
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$154M
2
+$104M
3
+$71.4M
4
Adage Capital Partners
Adage Capital Partners
Massachusetts
+$31.4M
5
PHS
PFM Health Sciences
California
+$25.2M

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
26
$1.27M
27
$1.27M
28
$1.21M
29
$1.06M
30
$1.04M
31
$1.02M
32
$972K
33
$939K
34
$850K
35
$809K
36
$667K
37
$577K
38
$514K
39
$392K
40
$286K
41
$258K
42
$256K
43
$252K
44
$218K
45
$134K
46
$100K
47
$91K
48
$77K
49
$71K
50
$69K
1
2
3